Skip to main content
OpenTrials
Completed

NCT Number: NCT05472376

Real-Life Study in Diabetic Macular Edema

The goal of this study is to evaluate the real-world outcomes of intravitreal anti-vascular endothelial growth factor (anti-VEGF) treatment in diabetic macular edema (DME) patients.

Completed

Looking for future studies?

Notify Me

Key information

Study type

Observational

Primary location

Kocaeli University School of Medicine, Kocaeli, None Selected, Turkey (Türkiye)

Loading trial locations.

About this study

The study included patients who were being observed in the retina departments of 8 tertiary hospitals in the Northern Marmara Region of Turkey (Istanbul's Asian Side, Kocaeli, and Sakarya). The records of DME patients treated with an anti-VEGF agent between January 2015 and December 2018 were reviewed.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Diabetic macular edema treated with intravitreal anti-VEGF injection
  • Having at least 4 or more annual examination visits

Exclusion criteria

  • Phacoemulsification surgery in the last 1 month
  • PRFK / grid / focal / micropulse in the last 4 months
  • Previous intraocular surgery (excluding PPV and phacoemulsification)

Treatment and study plan

retrospective study

Other

Retrospective study

Primary outcomes

  1. Visit and Intravitreal Injection Numbers

    Time frame: First year

    The primary outcomes were changes in best-corrected visual acuity and central macular thickness in the first year and frequency of visits and intravitreal anti-VEGF injections.

Sponsors and collaborators

Lead sponsor

Kocaeli University

Other

Registry information

Official study title

Real-World Outcomes of Anti-VEGF Treatment for Diabetic Macular Edema in Turkey: A Multicenter Retrospective Study, MARMASIA Study Group

Important dates

Study start
2020
Primary completion
2022
Study completion
2022
First posted
Jul 25, 2022
Registry last updated
Jul 25, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.